U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07892664) titled 'Reducing Arterial Inflammation Using Eplerenone and Statins in HIV' on Oct. 18.
Brief Summary: HIV has transitioned to a chronic disease in which well-treated persons remain at higher risk for heart disease when compared to the general population. Statin medications have been shown to reduce the number of events related to heart disease, but there are still individuals who will have complications from heart disease despite statin use. This study is being conducted to determine whether adding on another medication to statins called eplerenone, which has been shown to reduce inflammation in the heart vasculature among persons with HIV...